|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Virginia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing VirginiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
HemoSonics, LLC.
| | | Phone: | (434) 202-1032 | Year Established: | 2004 | Main Contact: | Timothy J. Fischer, President & CEO | | Other Contacts: | Deborah Winegar Ph.D., VP, Clinical Affairs David Bryant, VP, Quality Systems Thomas Givens, VP, Engineering Megan Shaw, VP, Marketing and Business Development Francesco Viola, Ph.D., Co-Founder & CSO William F. Walker, PhD, Co-Founder & CTO Megan Shaw, VP Marketing and Business Development Francesco Viola, Ph.D., Co-Founder & CSO William F. Walker, Ph.D., Co-Founder & CTO
| | Company Description | HemoSonics is a privately held medical device company founded to develop and bring to market innovative in vitro diagnostics to characterize hemostasis in a variety of clinical settings. These systems employ a patented approach named sonorheometry (SR), which is faster, easier to use, and has a lower cost than competing technologies.
Sonorheometry was invented by company founders Walker, Viola, and Lawrence while at the University of Virginia. This technology has undergone clinical and laboratory testing supported by a series of academic and business grants from the National Institutes of Health, the Wallace H. Coulter Foundation for Translational Research, the Office of Naval Research, and private investors. Sonorheometry has been demonstrated in a series of peer-reviewed scientific publications and has undergone both laboratory and clinical evaluation. Standalone prototypes are undergoing further clinical and laboratory evaluation. | |
|
|
|
|
|